Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1009020100080020079
Clinical Psychopharmacology and Neuroscience
2010 Volume.8 No. 2 p.79 ~ p.83
Metabolic Syndrome in Psychiatric Patients Treated with Antipsychotic Drugs in Thailand
Udomratn Pichet

Abstract
Recently, Thai psychiatrists have increased their attention to metabolic abnormalities among patients receiving antipsychotics, especially a condition called metabolic syndrome (MetS). Therefore, the objectives of this paper were to review the rate of MetS associated with antipsychotics, to compare the prevalence of MetS between those receiving first and second generation antipsychotics (FGAs, SGAs) and to find the associated factors of MetS in Thai patients. Reviewing of the PUBMED database and two Thai journals was conducted. Authors interested in this topic were also contacted. The inclusion and exclusion criteria were defined and finally, 4 papers that fulfilled the criteria were reviewed. It was found that the prevalence rate of MetS in Thai patients varied from 15.4% to 23.9% by the IDF criteria and it was higher, between 20.5% to 30.5%, by the updated ATP III criteria. The incidence rate, by the IDF criteria, in patients who took any type of antipsychotic for one year was 20%. The prevalence rate of MetS, by the IDF criteria, among those receiving FGAs and SGAs was 9.4% to 27.1% and 20% to 20.3%, respectively. Difference in rates of MetS was found in different regions of Thailand. The factors associated with MetS were the use of SGAs and a family history of hypertension. The prevalence rate of MetS in Thai psychiatric patients was rather lower than that from a study in Taiwan. The definition of MetS according to IDF is less likely to identify metabolically abnormal but non-obese individuals. Perhaps, the modified or updated ATP III criteria is more appropriate to detect MetS in Asian patients, particularly those in Thailand.
KEYWORD
Metabolic syndrome, Antipsychotics, Psychiatric patients, Thailand
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed